New York, NY (PRWEB) November 09, 2012
Boston Scientific Inc, which is facing thousands of transvaginal mesh lawsuits,has disclosed that the California Attorney General has launched a new investigation into sales of its vaginal mesh products, Bernstein Liebhard LLP reports. According to Boston Scientific’s latest 10-Q filing with the U.S. Securities and Exchange Commission (SEC), the company was informed in October 2012 that California and “several other state attorneys general offices intend to initiate a civil investigation into our sales of transvaginal surgical mesh products." Boston Scientific is named in some 2,500 vaginal mesh lawsuits in various federal and state courts across the country alleging personal injury associated with use of the company’s transvaginal mesh products designed to treat stress urinary incontinence and pelvic organ prolapse, the filing stated.*
“In light of the recent regulatory guidance concerning transvaginal mesh devices, as well as the growing number of vaginal mesh lawsuits currently pending against Boston Scientific and other manufacturers, it’s not at all surprising that the marketing of these products has come under additional scrutiny,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices, including transvaginal mesh. The firm is currently evaluating potential transvaginal mesh lawsuits on behalf of women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to vaginal mesh.
Transvaginal Mesh Lawsuits
Many of the transvaginal mesh lawsuits currently pending against Boston Scientific have been filed in In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation (“MDL No. 2326), now underway in U.S. District Court, Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey Grand, is serving on the Plaintiffs’ Steering Committee in the federal Boston Scientific transvaginal mesh litigation.
In addition to the Boston Scientific vaginal mesh lawsuits, several other transvaginal mesh litigations are currently pending in the Southern District of West Virginia, including In re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation (“MDL No. 2325”); In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation (“ MDL No. 2327”). Mr. Grand is also serving on the Plaintiffs’ Steering Committees in these litigations. In addition, Mr. Grand has been named Co-Liaison Counsel in two consolidated actions currently pending in New Jersey Superior Court, In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. L-6341-10.
In July 2011, the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious complications associated with the use of transvaginal mesh. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with pelvic organ prolapse repair were not rare. In January, the FDA ordered Boston Scientific and other manufacturers of transvaginal mesh to conduct post-market studies of their products to enable the agency to better understand the safety and effectiveness profiles of these devices. According to the FDA, it is considering reclassifying vaginal mesh used in the transvaginal repair of pelvic organ prolapse from Class II to Class III, which would subject such products to a greater degree of regulatory scrutiny.**
Women who suffered complications following implantation of transvaginal mesh may be entitled to compensation for their medical bills, pain and suffering, and other injuries. Bernstein Liebhard LLP is offering free lawsuit evaluations to any woman allegedly injured by vaginal mesh devices. A wealth of information regarding the firm's involvement with the ongoing pelvic mesh litigation can be found at Bernstein Liebhard's website, or by calling 1-877-779-1414 today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP